Advocacy

Policy resources for protecting access to quality cancer care.

NCOA members are positioned to educate decision-makers on how coverage and reimbursement issues affect cancer care delivery across North Carolina.

National Policy Resources — Local Advocacy Results

Make oncology voices heard in policy decisions.

As cancer care professionals who experience the challenges of providing quality cancer care first-hand, NCOA members are well positioned to educate decision-makers on how coverage and reimbursement issues affect cancer care delivery. State and federal legislation can significantly affect the financial viability of cancer programs across care settings, so members need the resources and confidence to advocate on issues that shape cancer care delivery.

Explore our website for the latest updates on oncology and healthcare-related legislation in North Carolina, and to learn more about NCOA's advocacy efforts at the state and federal levels.

Legislative Updates

The latest on legislation affecting cancer care in North Carolina.

Current Call to Action

November 4, 2026

NCOA and ASCO Submit Joint Comments to NC Medicaid on Proposed Medical Frailty Policy

NCOA worked with ASCO to draft and submit a joint letter to NC Medicaid with comments on the proposed Clinical Coverage Policy for H.R. 1 Medical Frailty Exclusions and the draft Medically Frail Diagnosis and Service Code List.

Sent on November 4 to Melanie Bush, Deputy Secretary of Medicaid, the letter raises concerns about administrative and documentation burdens on oncology providers and county staff, and about unclear automatic verification of exemptions for patients in active cancer treatment. It urges NC Medicaid to:

  • Treat an applicable diagnosis code for all malignant neoplasms, active hematologic malignancies, neoplasms of uncertain behavior, and serious treatment-related toxicities as independently sufficient for an automatic Tier 1 exclusion, and add cancer survivors within one year of completing active therapy.
  • Add ICD-10 code D70.1 (agranulocytosis secondary to cancer chemotherapy) and CAR-T and stem cell transplant codes to Tier 1.
  • Replace non-billable parent codes, such as D37–D48, with billable specific subcodes.
  • Establish a quarterly update process for new HCPCS and CPT codes.

ASCO's Recommended Code List for the Medical Frailty Exemption is attached to the letter. The comments aim to protect care for the more than 669,000 Medicaid expansion enrollees in North Carolina.

Current Call to Action

Ensure patients receive timely access to cancer care.

Join NCOA and ASCO in urging members of the House Health Committee to support HB 434 so patients with cancer in North Carolina can access care in a timely manner.

The background

NCOA and ASCO support policies that reduce cost while preserving quality cancer care. However, payer utilization management approaches like prior authorization can raise barriers to appropriate care for individuals with cancer if they are not implemented thoughtfully.

Why it matters

NCOA and ASCO support the NC Cares First Act, HB 434, prior authorization reform legislation that would help reduce administrative burden, accommodate the special needs of patients with cancer, and improve transparency.

Take action on HB 434

Contact decision-makers through the ASCO action portal and support prior authorization reform.

Take Action

Contact

Your voice matters.

Whether you want to share a concern or pain point, flag a piece of legislation, suggest a resource, or join our Policy Committee, get in touch with Nicole Banks.

Email Nicole Banks